BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23867757)

  • 1. Zoledronic acid inhibits human osteoblast activities.
    Basso FG; Silveira Turrioni AP; Hebling J; de Souza Costa CA
    Gerontology; 2013; 59(6):534-41. PubMed ID: 23867757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
    Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
    J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts.
    Basso FG; Pansani TN; de Oliveira CF; Turrioni AP; Soares DG; Hebling J; Costa CA
    Braz Dent J; 2013; 24(6):551-8. PubMed ID: 24474348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zoledronic acid on odontoblast-like cells.
    Basso FG; Turrioni AP; Hebling J; de Souza Costa CA
    Arch Oral Biol; 2013 May; 58(5):467-73. PubMed ID: 23092609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
    Schindeler A; Little DG
    Biochem Biophys Res Commun; 2005 Dec; 338(2):710-6. PubMed ID: 16243296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells.
    Açil Y; Möller B; Niehoff P; Rachko K; Gassling V; Wiltfang J; Simon MJ
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e229-35. PubMed ID: 22082730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid.
    Basso FG; Turrioni AP; Soares DG; Bagnato VS; Hebling J; de Souza Costa CA
    Support Care Cancer; 2014 Oct; 22(10):2741-8. PubMed ID: 24801347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
    Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
    Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
    Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
    Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of bisphosphonates on osteoblasts in vitro.
    Naidu A; Dechow PC; Spears R; Wright JM; Kessler HP; Opperman LA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):5-13. PubMed ID: 18504149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of extracellular matrix proteins in human periodontal ligament cells during mineralization in vitro.
    Nohutcu RM; McCauley LK; Koh AJ; Somerman MJ
    J Periodontol; 1997 Apr; 68(4):320-7. PubMed ID: 9150036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryopreservation of osteoblast-like cells: viability and differentiation with replacement of fetal bovine serum in vitro.
    Reuther T; Kettmann C; Scheer M; Kochel M; Iida S; Kubler AC
    Cells Tissues Organs; 2006; 183(1):32-40. PubMed ID: 16974093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
    Zara S; De Colli M; di Giacomo V; Zizzari VL; Di Nisio C; Di Tore U; Salini V; Gallorini M; Tetè S; Cataldi A
    Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
    Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
    Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hydrogen peroxide (H2O2) on alkaline phosphatase activity and matrix mineralization of odontoblast and osteoblast cell lines.
    Lee DH; Lim BS; Lee YK; Yang HC
    Cell Biol Toxicol; 2006 Jan; 22(1):39-46. PubMed ID: 16463018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
    Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
    Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotective effects of melatonin on zoledronic acid-treated human osteoblasts.
    Camacho-Alonso F; Urrutia-Rodríguez I; Oñate-Cabrerizo D; Oñate-Sánchez RE; Rodríguez-Lozano FJ
    J Craniomaxillofac Surg; 2017 Aug; 45(8):1251-1257. PubMed ID: 28552199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.